# Assessment of Glycemic Control in Patients With Type 2 Diabetes Mellitus and Late Stage Chronic Kidney Disease

> **NCT03383627** · NA · COMPLETED · sponsor: **Northwell Health** · enrollment: 80 (actual)

## Conditions studied

- Diabetes
- Kidney Diseases

## Interventions

- **DEVICE:** Continuous Glucose Monitoring

## Key facts

- **NCT ID:** NCT03383627
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-30
- **Primary completion:** 2018-08-21
- **Final completion:** 2018-08-21
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2021-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03383627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03383627, "Assessment of Glycemic Control in Patients With Type 2 Diabetes Mellitus and Late Stage Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03383627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*